Cargando…

Short or Long Interval between Priming and Boosting: Does It Impact on the Vaccine Immunogenicity?

Characterizing the impact of the vaccination schedule on the induction of B and T cell immune responses is critical for improving vaccine immunogenicity. Here we compare the effect of a short (4 weeks) or a long (18 weeks) interval between priming and boosting in mice, using a model vaccine formulat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pettini, Elena, Pastore, Gabiria, Fiorino, Fabio, Medaglini, Donata, Ciabattini, Annalisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003773/ https://www.ncbi.nlm.nih.gov/pubmed/33804604 http://dx.doi.org/10.3390/vaccines9030289

Ejemplares similares

Heterologous Prime-Boost Combinations Highlight the Crucial Role of Adjuvant in Priming the Immune System
por: Ciabattini, Annalisa, et al.
Publicado: (2018)

Prime-Boost Strategies in Mucosal Immunization Affect Local IgA Production and the Type of Th Response
por: Fiorino, Fabio, et al.
Publicado: (2013)

Modulation of Primary Immune Response by Different Vaccine Adjuvants
por: Ciabattini, Annalisa, et al.
Publicado: (2016)

Computational Analysis of Multiparametric Flow Cytometric Data to Dissect B Cell Subsets in Vaccine Studies
por: Lucchesi, Simone, et al.
Publicado: (2019)

CD4(+) T Cell Priming as Biomarker to Study Immune Response to Preventive Vaccines
por: Ciabattini, Annalisa, et al.
Publicado: (2013)

Transcriptomics of the Vaccine Immune Response: Priming With Adjuvant Modulates Recall Innate Responses After Boosting
por: Santoro, Francesco, et al.
Publicado: (2018)

Distribution of Primed T Cells and Antigen-Loaded Antigen Presenting Cells Following Intranasal Immunization in Mice
por: Ciabattini, Annalisa, et al.
Publicado: (2011)

Optimized Protocol for the Detection of Multifunctional Epitope-Specific CD4(+) T Cells Combining MHC-II Tetramer and Intracellular Cytokine Staining Technologies
por: Pastore, Gabiria, et al.
Publicado: (2019)

A third dose of mRNA-1273 vaccine improves SARS-CoV-2 immunity in HCT recipients with low antibody response after 2 doses
por: Pettini, Elena, et al.
Publicado: (2022)

Profiling the B cell immune response elicited by vaccination against the respiratory virus SARS-CoV-2
por: Pettini, Elena, et al.
Publicado: (2022)

Does Nirmatrelvir/Ritonavir Influence the Immune Response against SARS-CoV-2, Independently from Rebound?
por: Panza, Francesca, et al.
Publicado: (2023)

Long-Term Anti-Bacterial Immunity against Systemic Infection by Salmonella enterica Serovar Typhimurium Elicited by a GMMA-Based Vaccine
por: Fiorino, Fabio, et al.
Publicado: (2021)

Evidence of SARS-CoV-2-Specific Memory B Cells Six Months After Vaccination With the BNT162b2 mRNA Vaccine
por: Ciabattini, Annalisa, et al.
Publicado: (2021)

Trajectory of Spike-Specific B Cells Elicited by Two Doses of BNT162b2 mRNA Vaccine
por: Ciabattini, Annalisa, et al.
Publicado: (2023)

B cell response after SARS-CoV-2 mRNA vaccination in people living with HIV
por: Polvere, Jacopo, et al.
Publicado: (2023)

Vaginal Immunization to Elicit Primary T-Cell Activation and Dissemination
por: Pettini, Elena, et al.
Publicado: (2013)

The third dose of mRNA SARS-CoV-2 vaccines enhances the spike-specific antibody and memory B cell response in myelofibrosis patients
por: Fiorino, Fabio, et al.
Publicado: (2022)

Characterization of the Antigen-Specific CD4(+) T Cell Response Induced by Prime-Boost Strategies with CAF01 and CpG Adjuvants Administered by the Intranasal and Subcutaneous Routes
por: Ciabattini, Annalisa, et al.
Publicado: (2015)

Monitoring Anti-PEG Antibodies Level upon Repeated Lipid Nanoparticle-Based COVID-19 Vaccine Administration
por: Guerrini, Giuditta, et al.
Publicado: (2022)

The Slower Antibody Response in Myelofibrosis Patients after Two Doses of mRNA SARS-CoV-2 Vaccine Calls for a Third Dose
por: Fiorino, Fabio, et al.
Publicado: (2021)

Role of the Microbiota in the Modulation of Vaccine Immune Responses
por: Ciabattini, Annalisa, et al.
Publicado: (2019)

From Bivariate to Multivariate Analysis of Cytometric Data: Overview of Computational Methods and Their Application in Vaccination Studies
por: Lucchesi, Simone, et al.
Publicado: (2020)

Interferon-γ from Brain Leukocytes Enhances Meningitis by Type 4 Streptococcus pneumoniae
por: Pettini, Elena, et al.
Publicado: (2015)

Immunogenicity of a Bivalent Adjuvanted Glycoconjugate Vaccine against Salmonella Typhimurium and Salmonella Enteritidis
por: Fiorino, Fabio, et al.
Publicado: (2017)

Shelter from the cytokine storm: pitfalls and prospects in the development of SARS-CoV-2 vaccines for an elderly population
por: Ciabattini, Annalisa, et al.
Publicado: (2020)

Reactogenicity and immunogenicity of heterologous prime-boost immunization with COVID-19 vaccine
por: Nguyen, Thuy Trang, et al.
Publicado: (2022)

A Stochastic Model for CD4+ T Cell Proliferation and Dissemination Network in Primary Immune Response
por: Boianelli, Alessandro, et al.
Publicado: (2015)

Immune Memory After Respiratory Infection With Streptococcus pneumoniae Is Revealed by in vitro Stimulation of Murine Splenocytes With Inactivated Pneumococcal Whole Cells: Evidence of Early Recall Responses by Transcriptomic Analysis
por: Moscardini, Isabelle Franco, et al.
Publicado: (2022)

P19-58 LB. Comparison of the immunogenicity in humans and rhesus macaques of vaccines consisting of DNA priming and MVA boosting and MVA priming and boosting
por: Robinson, HL, et al.
Publicado: (2009)

A Heterologous Prime/Boost Vaccination Strategy Enhances the Immunogenicity of Therapeutic Vaccines for Hepatitis C Virus
por: Fournillier, Anne, et al.
Publicado: (2013)

Using IFN-gamma release assay to confirm tuberculin skin test improves the screening of latent tuberculosis infection in Italian healthcare workers
por: Olivieri, Raffaela, et al.
Publicado: (2016)

Immunogenicity of Low-Dose Prime-Boost Vaccination of mRNA Vaccine CV07050101 in Non-Human Primates
por: van Doremalen, Neeltje, et al.
Publicado: (2021)

Immunogenicity of low dose prime-boost vaccination of mRNA vaccine CV07050101 in non-human primates
por: van Doremalen, Neeltje, et al.
Publicado: (2021)

Short- and Long-Interval Prime-Boost Vaccination with the Candidate Vaccines MVA-SARS-2-ST and MVA-SARS-2-S Induces Comparable Humoral and Cell-Mediated Immunity in Mice
por: Kalodimou, Georgia, et al.
Publicado: (2023)

Recombinant Haemagglutinin Derived From the Ciliated Protozoan Tetrahymena thermophila Is Protective Against Influenza Infection
por: Jawinski, Karina, et al.
Publicado: (2019)

Ebola-GP DNA Prime rAd5-GP Boost: Influence of Prime Frequency and Prime/Boost Time Interval on the Immune Response in Non-human Primates
por: Marcus, Hadar, et al.
Publicado: (2021)

Qualitative differences in cellular immunogenicity elicited by hepatitis C virus T-Cell vaccines employing prime-boost regimens
por: Tan, Wendy G., et al.
Publicado: (2017)

Immunogenicity of prime-boost protein subunit vaccine strategies against SARS-CoV-2 in mice and macaques
por: Tan, Hyon-Xhi, et al.
Publicado: (2021)

Immunogenicity and Safety of Homologous and Heterologous Prime–Boost Immunization with COVID-19 Vaccine: Systematic Review and Meta-Analysis
por: Cheng, Haoyue, et al.
Publicado: (2022)

A heuristic study of the distribution of primes in short and not-so-short intervals
por: Sanchis-Lozano, Miguel-Angel
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_nqbkgqo3e6lkjaqmc156nsgf8d